Elevai Labs, Inc. (Ticker: ELAB) is an innovative technology firm specializing in artificial intelligence and machine learning solutions that drive transformative efficiencies in various industries, notably healthcare and finance. By leveraging sophisticated data analytics platforms, Elevai Labs empowers organizations to make informed decisions and unlock actionable insights from intricate datasets. Positioned strategically within the burgeoning tech landscape, the company is poised to leverage emerging market trends, offering substantial value and operational improvements to clients and stakeholders alike. Its commitment to advancing AI-driven technologies underscores Elevai Labs' potential for sustainable growth and competitive advantage.
| Revenue (TTM) | $1.27M |
| Gross Profit (TTM) | -803,280 |
| EBITDA | $-9.03M |
| Operating Margin | -484.70% |
| Return on Equity | -107.90% |
| Return on Assets | -33.30% |
| Revenue/Share (TTM) | $9.80 |
| Book Value | $6.51 |
| Price-to-Book | 0.64 |
| Price-to-Sales (TTM) | 6.36 |
| EV/Revenue | 0.742 |
| EV/EBITDA | — |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -45.80% |
| Shares Outstanding | $4.54M |
| Float | $4.54M |
| % Insiders | 0.06% |
| % Institutions | 1.57% |